Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhodopsin | 5 | 2014 | 202 | 1.220 |
Why?
|
| Microglia | 7 | 2022 | 1370 | 0.970 |
Why?
|
| Retinal Degeneration | 3 | 2014 | 413 | 0.890 |
Why?
|
| Alzheimer Disease | 9 | 2024 | 8717 | 0.770 |
Why?
|
| Plaque, Amyloid | 3 | 2021 | 769 | 0.740 |
Why?
|
| Amyloid beta-Peptides | 8 | 2024 | 3886 | 0.700 |
Why?
|
| Receptors, Immunologic | 2 | 2021 | 1418 | 0.540 |
Why?
|
| Presenilin-1 | 1 | 2020 | 665 | 0.530 |
Why?
|
| Endoplasmic Reticulum | 3 | 2011 | 1132 | 0.520 |
Why?
|
| Cromolyn Sodium | 3 | 2021 | 76 | 0.490 |
Why?
|
| Retinitis Pigmentosa | 4 | 2012 | 395 | 0.490 |
Why?
|
| Drosophila Proteins | 3 | 2014 | 1705 | 0.440 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 3702 | 0.390 |
Why?
|
| Adenosine Triphosphatases | 2 | 2010 | 840 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 3440 | 0.310 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 1722 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 18330 | 0.260 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 760 | 0.240 |
Why?
|
| Neuroprotective Agents | 3 | 2021 | 956 | 0.220 |
Why?
|
| Gene Silencing | 1 | 2010 | 1505 | 0.220 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2020 | 1117 | 0.220 |
Why?
|
| Protein Folding | 3 | 2014 | 869 | 0.210 |
Why?
|
| Drosophila | 1 | 2010 | 1509 | 0.210 |
Why?
|
| Energy Metabolism | 1 | 2014 | 2906 | 0.200 |
Why?
|
| Retina | 2 | 2010 | 2659 | 0.200 |
Why?
|
| Phagocytosis | 4 | 2022 | 1526 | 0.200 |
Why?
|
| Cognition | 1 | 2019 | 7059 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 694 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2024 | 9551 | 0.180 |
Why?
|
| Interleukin-3 | 1 | 2021 | 425 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 518 | 0.170 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.160 |
Why?
|
| Brain | 5 | 2024 | 27163 | 0.150 |
Why?
|
| Animals | 15 | 2024 | 168965 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2018 | 228 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 704 | 0.130 |
Why?
|
| Dependovirus | 1 | 2020 | 720 | 0.120 |
Why?
|
| Mice | 10 | 2024 | 81912 | 0.120 |
Why?
|
| Protein Hydrolysates | 1 | 2014 | 7 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2022 | 876 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2887 | 0.120 |
Why?
|
| Tolonium Chloride | 1 | 2014 | 23 | 0.120 |
Why?
|
| Caspase 9 | 1 | 2014 | 184 | 0.110 |
Why?
|
| Astrocytes | 1 | 2021 | 1352 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14476 | 0.110 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 285 | 0.100 |
Why?
|
| Electroretinography | 1 | 2014 | 524 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2014 | 565 | 0.090 |
Why?
|
| Proteostasis Deficiencies | 1 | 2011 | 38 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2551 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1804 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3227 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1562 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2021 | 3076 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 1481 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2012 | 457 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11923 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2201 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5022 | 0.070 |
Why?
|
| Reference Values | 1 | 2013 | 4918 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2061 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18989 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2024 | 5141 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1407 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1319 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22361 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2010 | 2931 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3139 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12790 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 3738 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2592 | 0.050 |
Why?
|
| Mitochondria | 1 | 2014 | 3678 | 0.040 |
Why?
|
| Proteomics | 1 | 2014 | 3913 | 0.040 |
Why?
|
| Humans | 10 | 2024 | 767040 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2824 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 1207 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12793 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 30211 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1492 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2019 | 399 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2018 | 246 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22254 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 869 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1014 | 0.030 |
Why?
|
| tau Proteins | 1 | 2024 | 2106 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2021 | 2345 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 895 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 16036 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 572 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2019 | 1811 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2086 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18063 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23621 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15567 | 0.020 |
Why?
|
| Male | 4 | 2024 | 364203 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7587 | 0.020 |
Why?
|
| Cytokines | 1 | 2019 | 7446 | 0.010 |
Why?
|
| Female | 3 | 2024 | 396660 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9517 | 0.010 |
Why?
|
Concepts
(100)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_